Extraneuronal roles of cyclin-dependent kinase 5

被引:99
作者
Rosales, Jesusa L. [1 ]
Lee, Ki-Young [1 ]
机构
[1] Univ Calgary, Dept Cell Biol & Anat, So Alberta Canc Res & Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada
关键词
D O I
10.1002/bies.20473
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclin-dependent kinase 5 (Cdk5) is recognized as an essential molecule in the brain, where it regulates several neuronal activities, including cytoskeletal remodeling and synaptic transmission. While activity of Cdk5 has primarily been associated with neurons, there are now substantial data indicating that the kinase's activity and function are more general. An increasing body of evidence has established Cdk5 kinase activity, the presence of the Cdk5 activators, p35 and p39, and Cdk5 functions in non-neuronal cells, including myocytes, pancreatic beta-cells, monocytic and neutrophilic leucocytes, glial cells and germ cells. In this review, we present the diverse roles of Cdk5 in several extraneuronal paradigms. The unique properties of each of the different cell types appear to involve distinct means of Cdk5 regulation and function. The potential mechanisms through which Cdk5 regulates extraneuronal cell activities such as exocytosis, gene transcription, wound healing and senescence are discussed.
引用
收藏
页码:1023 / 1034
页数:12
相关论文
共 98 条
  • [1] Cellular senescence requires CDK5 repression of Rac1 activity
    Alexander, K
    Yang, HS
    Hinds, PW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) : 2808 - 2819
  • [2] Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus
    Altucci, L
    Addeo, R
    Cicatiello, L
    Germano, D
    Pacilio, C
    Battista, T
    Cancemi, M
    Petrizzi, VB
    Bresciani, F
    Weisz, A
    [J]. ENDOCRINOLOGY, 1997, 138 (03) : 978 - 984
  • [3] Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis
    Bajaj, NPS
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2000, 1 (05): : 319 - 327
  • [4] Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
    Bibb, JA
    Snyder, GL
    Nishi, A
    Yan, Z
    Meijer, L
    Fienberg, AA
    Tsai, LH
    Kwon, YT
    Girault, JA
    Czernik, AJ
    Huganir, RL
    Hemmings, HC
    Nairn, AC
    Greengard, P
    [J]. NATURE, 1999, 402 (6762) : 669 - 671
  • [5] Neuronal peptide release is limited by secretory granule mobility
    Burke, NV
    Han, WP
    Li, DQ
    Takimoto, K
    Watkins, SC
    Levitan, ES
    [J]. NEURON, 1997, 19 (05) : 1095 - 1102
  • [6] Changes in the expression of novel Cdk5 activator messenger RNA (p39(nck5ai) mRNA) during rat brain development
    Cai, XH
    Tomizawa, K
    Tang, DM
    Lu, YF
    Moriwaki, A
    Tokuda, M
    Nagahata, S
    Hatase, O
    Matsui, H
    [J]. NEUROSCIENCE RESEARCH, 1997, 28 (04) : 355 - 360
  • [7] Replicative senescence: An old lives' tale?
    Campisi, J
    [J]. CELL, 1996, 84 (04) : 497 - 500
  • [8] Catania A, 2001, NEURO-ONCOLOGY, V3, P89, DOI 10.1093/neuonc/3.2.89
  • [9] Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality
    Chae, T
    Kwon, YT
    Bronson, R
    Dikkes, P
    Li, E
    Tsai, LH
    [J]. NEURON, 1997, 18 (01) : 29 - 42
  • [10] Up-regulation of Egr1 by 1,25-dihydroxyvitamin D3 contributes to increased expression of p35 activator of cyclin-dependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation
    Chen, F
    Wang, Q
    Wang, XN
    Studzinski, GP
    [J]. CANCER RESEARCH, 2004, 64 (15) : 5425 - 5433